From the Editor: Test Consumer, Beware
At the beginning of November FDA issued a safety communication to alert the public about concerns regarding DTC genetic tests with unapproved claims.
Read MorePosted by Steve Halasey | Nov 7, 2018 | Controls |
At the beginning of November FDA issued a safety communication to alert the public about concerns regarding DTC genetic tests with unapproved claims.
Read MorePosted by Steve Halasey | Nov 7, 2018 | Research |
Researchers presented data from clinical experience study of ThyGenX and ThyraMIR testing at the annual meeting of the American Thyroid Association.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Research |
A study of variant reclassification results shows that 25% of all reported variants of uncertain significance were reclassified over a 10-year period.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Research |
The test supports international guidelines for treating antibiotic-resistant STIs.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Standards |
The cell line-derived myeloid cancer reference standard contains 22 mutations across 19 oncology-relevant genes.
Read More